GLP-1 receptor agonists work by mimicking a natural hormone that helps regulate appetite, blood sugar, and digestion
[2] Whilst semaglutide does not typically cause cognitive impairment, patients taking both medications should be aware of these potential effects, which may impact daily functioning, work performance, or driving ability
Furthermore, the known benefit of weight loss for certain skin conditions may be further potentiated by GLP-1 agonists
Minor increases in lipase levels were observed across all renal function groups, which is consistent with increases observed in patients with type 2 diabetes treated with liraglutide [33]
Individuals may prefer to avoid milk products, but with proper planning, these can be safely incorporated into the diet
Food and Drug Administration has approved liraglutide, semaglutide, and dulaglutide as treatment options to prevent cardiovascular disease outcomes in patients with diabetes